Prevalence of venous thromboembolism in patients undergoing diagnostic venous ultrasound during the first SARS-CoV-2 pandemic
Vasa · 2023
DOI: 10.1024/0301-1526/a001052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vasa, 2023. Verfasst von Guglielmo La Torre und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Birmingham NHS Foundation Trust, Birmingham, UK. Hauptthemen laut MEDLINE: Venous Thromboembolism, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Venous thromboembolism appears to be associated with severe COVID-19 infection than in those without it. However, this varies considerably depending on the cohort studied. The aims of this single-centre, multi-site retrospective cross-sectional study were to assess the number of all venous scans performed in the first month of pandemic in a large university teaching hospital, to evaluate the incidence of deep venous thrombosis (DVT), and assess the predictive ability of the clinical information available on the electronic patient record in planning work-up for DVT and prioritising ultrasound scans. Patients and methods: All consecutive patients undergoing venous ultrasound for suspected acute DVT between 1st of March and 30th of April 2020 were considered. Primary outcome was the proportion of scans positive for DVT; the secondary outcomes included association of a positive SARS-CoV-2 PCR test, demographic, clinical factors, and Wells scores.
Results
819 ultrasound scans were performed on 762 patients across the Trust in March and April 2020. This number was comparable to the corresponding pre-pandemic cohort from 2019. The overall prevalence of DVT in the studied cohort was 16.1% and was higher than before the pandemic (11.5%, p=.047). Clinical symptoms consistent with COVID-19, irrespective of the SARS-CoV-2 PCR test result (positive_COVID_PCR OR 4.97, 95%CI 2.31–10.62, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
- Royal Centre for Defence Medicine, Queen Elizabeth Hospital, Birmingham, UK.
- Medical Research Council Biostatistics Unit, Cambridge, UK.
- Institute of inflammation and ageing University of Birmingham, UK.
ORCID-Profile: Guglielmo La Torre, Gowshan Rajeswaran, Robert Goudie, Alok Tiwari, Maciej Tadeusz Juszczak
Förderung
- Medical Research Council
Zitieren
APA
La Torre, G., Nagra, R., Wijesinghe, H., Rajeswaran, G., Riya, J., Abdulkhaliq, S., Barker, T., Ganeshan, A., Goudie, R., Hosaam, N., Tiwari, A., & Juszczak, M. T. (2023). Prevalence of venous thromboembolism in patients undergoing diagnostic venous ultrasound during the first SARS-CoV-2 pandemic. Vasa. https://doi.org/10.1024/0301-1526/a001052
Vancouver
La Torre G, Nagra R, Wijesinghe H, Rajeswaran G, Riya J, Abdulkhaliq S, et al. Prevalence of venous thromboembolism in patients undergoing diagnostic venous ultrasound during the first SARS-CoV-2 pandemic. Vasa. 2023. doi:10.1024/0301-1526/a001052
BibTeX
@article{LaTorre2023,
author = {La Torre, Guglielmo and Nagra, Raveenjot and Wijesinghe, Haren and Rajeswaran, Gowshan and Riya, Jain and Abdulkhaliq, Scerif and Barker, Tom and Ganeshan, Arul and Goudie, Robert and Hosaam, Nasr and Tiwari, Alok and Juszczak, Maciej Tadeusz},
title = {Prevalence of venous thromboembolism in patients undergoing diagnostic venous ultrasound during the first SARS-CoV-2 pandemic},
journal = {Vasa},
year = {2023},
doi = {10.1024/0301-1526/a001052}
}
EUVIMED